SCHEMBL5526149

SCHEMBL5526149

O=CC(Br)c1ccc(O)c([N+](=O)[O-])c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH5A1 P51649 1/20 0.54
ABAT P80404 1/20 0.54
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 2/20 0.50
GPR35 Q9HC97 2/20 0.50
TP53 P04637 1/20 0.50
HPGD P15428 1/20 0.50
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MAPT P10636 3/20 0.47
GAA P10253 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22440024 0.81 ALDH1A1 (0.49) ALDH1A1MAPK1TSHRSMN1; SMN2HSD17B10
SCHEMBL20500959 0.81 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2MAPTGAACA1
SCHEMBL2998296 0.81 VCAM1 (0.54) ALDH1A1MAPK1TSHRSMN1; SMN2L3MBTL1
SCHEMBL22440060 0.81 VCAM1 (0.54) ALDH1A1MAPK1TSHRSMN1; SMN2L3MBTL1
SCHEMBL4338371 0.81 ALDH1A1 (0.49) ALDH1A1MAPK1TSHRSMN1; SMN2HSD17B10
SCHEMBL12614866 0.77 MAPT (0.46) ALDH1A1HPGDTSHRSMN1; SMN2L3MBTL1
SCHEMBL20500983 0.77 TUBB4A (0.48) ALDH1A1TSHRSMN1; SMN2ALOX15HSD17B10
SCHEMBL4346881 0.77 TUBB4A (0.48) ALDH1A1TSHRSMN1; SMN2ALOX15HSD17B10
SCHEMBL15688141 0.77 SHBG (0.44) ALDH1A1MAPK1HPGDTSHRALOX15
SCHEMBL1026668 0.76 ALDH1A1 (0.56) ALDH5A1ABATALDH1A1MAPK1GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1748993-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-02-07 EP disclosed
WO-2005116000-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2005-12-08 WO disclosed
EP-1401427-A4 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMA (US) 2004-12-01 EP disclosed
EP-1401427-A2 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM Agouron Pharmaceuticals, Inc. (US) 2004-03-31 EP disclosed
WO-2002098363-A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed